Artiach Hortelano, Pilar
Martens, Marieke A. G. http://orcid.org/0000-0003-0108-1327
Pringle, Abigail
Harmer, Catherine J
Article History
Received: 27 June 2022
Accepted: 31 May 2023
First Online: 20 June 2023
Declarations
:
: CJH has received consultancy fees from P1vital Ltd., Janssen Pharmaceuticals, Sage Therapeutics, Pfizer, Zogenix, Compass Pathways, and Lundbeck. CJH holds grant income from Zogenix, UCB Pharma, Pfizer, Janssen Pharmaceuticals.
: The views expressed here are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health.